Accrued expenses and other liabilities consisted
of the following:
| | |
April 30, 2026 | | |
October 31,
2025 | |
| | |
| | |
| |
| Accrued expenses (1) | |
$ | 8,112,602 | | |
$ | 9,245,092 | |
| Board compensation payable | |
| 75,000 | | |
| 75,000 | |
| Due to a third-party (2) | |
| 952,181 | | |
| 952,181 | |
| Other payable | |
| 914,505 | | |
| 746,450 | |
| Accrued expenses and other liabilities | |
$ | 10,054,288 | | |
$ | 11,018,723 | |
| (1) | The balance represented accrued contract expenses. |
| (2) | The balance was advanced by Dr. Guohua Zhang (former Chief Executive Officer and Chairman of the Board of the Company) before October 31, 2024. |
|